Release Date: 02/03/21 08:53 Summary: Change of Director's Interest Notice - Andrew Russell Price Sensitive: No Download Document 281.67KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%